Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease V: Surgical Management
Inflammatory Bowel Disease III: Crohn's Disease
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Drugs for Treatment of Ulcerative Colitis in IBD
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 1, 2026

Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
Yin Jiang1, JingLin Gao1, YaLi Huang1
1Department of Rheumatology and Immunology, Liuzhou Key Laboratory of Prevention and Treatment of Rheumatic Diseases, The Fourth Affiliated Hospital of Guangxi Medical University (Liuzhou Worker's Hospital), Liuzhou, China.
The RNA-binding protein TARDBP reduces inflammation in ulcerative colitis by degrading NFATC1 mRNA. This TARDBP-NFATC1 pathway offers a potential therapeutic target for improving intestinal barrier function.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: